Zacks: Analysts Anticipate Marrone Bio Innovations Inc (NASDAQ:MBII) to Announce -$0.04 EPS
Wall Street analysts expect Marrone Bio Innovations Inc (NASDAQ:MBII) to post earnings per share of ($0.04) for the current quarter, according to Zacks. Two analysts have issued estimates for Marrone Bio Innovations’ earnings, with estimates ranging from ($0.05) to ($0.03). Marrone Bio Innovations reported earnings per share of ($0.05) during the same quarter last year, which would indicate a positive year over year growth rate of 20%. The business is scheduled to issue its next earnings report on Thursday, March 12th.
According to Zacks, analysts expect that Marrone Bio Innovations will report full year earnings of ($0.29) per share for the current year. For the next fiscal year, analysts expect that the company will post earnings of ($0.15) per share, with EPS estimates ranging from ($0.20) to ($0.07). Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Marrone Bio Innovations.
MBII has been the topic of several research reports. National Securities restated a “buy” rating and set a $2.50 price objective on shares of Marrone Bio Innovations in a research note on Friday, August 9th. HC Wainwright restated a “buy” rating and set a $2.50 price objective on shares of Marrone Bio Innovations in a research note on Monday, August 12th.
NASDAQ MBII traded down $0.03 on Monday, hitting $1.05. 42,862 shares of the stock traded hands, compared to its average volume of 120,616. The stock has a 50-day moving average of $1.26 and a 200 day moving average of $1.41. Marrone Bio Innovations has a twelve month low of $1.02 and a twelve month high of $1.92. The company has a market capitalization of $140.07 million, a P/E ratio of -5.00 and a beta of -0.22. The company has a current ratio of 1.05, a quick ratio of 0.69 and a debt-to-equity ratio of 0.94.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation.
Recommended Story: Backdoor Roth IRA
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.